164 related articles for article (PubMed ID: 31096518)
1. Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report.
Zhou H; Wei Q; Wu H; Tang M; Yang S; Liu Y; Qin L
Medicine (Baltimore); 2019 May; 98(20):e15705. PubMed ID: 31096518
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
3. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
BMJ Open; 2018 Jun; 8(6):e020286. PubMed ID: 29934383
[TBL] [Abstract][Full Text] [Related]
4. A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.
Kabuki T; Nakanishi R; Hisatake S; Fujii T; Dobashi S; Wakakura S; Kiuchi S; Fujino T; Ikeda T
J Cardiol; 2017 Aug; 70(2):163-168. PubMed ID: 27979674
[TBL] [Abstract][Full Text] [Related]
5. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
7. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
Beyer-Westendorf J; Schellong SM; Gerlach H; Rabe E; Weitz JI; Jersemann K; Sahin K; Bauersachs R;
Lancet Haematol; 2017 Mar; 4(3):e105-e113. PubMed ID: 28219692
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.
Khorana AA; Vadhan-Raj S; Kuderer NM; Wun T; Liebman H; Soff G; Belani C; O'Reilly EM; McBane R; Eikelboom J; Damaraju CV; Beyers K; Dietrich F; Kakkar AK; Riess H; Peixoto RD; Lyman GH
Thromb Haemost; 2017 Nov; 117(11):2135-2145. PubMed ID: 28933799
[TBL] [Abstract][Full Text] [Related]
10. Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report.
Zolfaghari Emameh R; Heshmatnia J
J Med Case Rep; 2023 Mar; 17(1):101. PubMed ID: 36934279
[TBL] [Abstract][Full Text] [Related]
11. Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.
Yagi S; Nishiyama S; Abe T; Sata M
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635311
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
[TBL] [Abstract][Full Text] [Related]
13. A Case Report of Henoch-Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban.
Chung EY; Chen J; Roxburgh S
Nephrology (Carlton); 2018 Mar; 23(3):289-290. PubMed ID: 29461002
[No Abstract] [Full Text] [Related]
14. Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE).
Zhang X; Cai Q; Wang X; Liao K; Hu C; Chen H
J Thromb Thrombolysis; 2021 Oct; 52(3):863-871. PubMed ID: 33674983
[TBL] [Abstract][Full Text] [Related]
15. Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature.
Wu HD; Cao HY; Song ZK; Yang S; Tang ML; Liu Y; Qin L
World J Clin Cases; 2019 Feb; 7(3):382-388. PubMed ID: 30746380
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban plus Percutaneous catheter-directed treatment for a patient with massive pulmonary embolism and colporrhagia.
Wang W
Am J Emerg Med; 2018 Aug; 36(8):1522.e5-1522.e7. PubMed ID: 29709396
[TBL] [Abstract][Full Text] [Related]
18. Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.
Singer AJ; Xiang J; Kabrhel C; Merli GJ; Pollack C; Tapson VF; Wildgoose P; Peacock WF
Acad Emerg Med; 2016 Nov; 23(11):1280-1286. PubMed ID: 27537530
[TBL] [Abstract][Full Text] [Related]
19. A Case of Isolated Unilateral Right Renal Vein Thrombosis Associated with Bilateral Pulmonary Embolism Treated with Rivaroxaban a Direct-Acting Oral Anticoagulant.
Matta A; Elenizi K; AlHarthi R; Moussallem N; Elhajjaji N; Lhermusier T; Carrié D
Am J Case Rep; 2019 Aug; 20():1152-1154. PubMed ID: 31383838
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of rivaroxaban in prevention and treatment of postoperative deep vein thrombosis for severe traumatic brain injury].
Zhang ZL; Liu WM; Zhang Y; Wang GH; Yan C; Wang HQ; Huang QB
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3558-3561. PubMed ID: 29275595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
